After being severely affected by the economic recession, the European cosmetic surgery, facial-aesthetics and medical laser market recovered in 2010, and is expected to reach over $1.3 billion by 2017.

Growth will be driven by increased use of facial injectable products, such as botulinum toxin A and dermal fillers, as well as by the recovery of the aesthetic laser market.

The market for injectable facial products continued to grow through the recession, and has proven to be extremely popular as a non-surgical alternative to cosmetic surgery. Additional competitors to Botox® have begun infiltrating the botulinum market, making it potentially one of the most competitive European aesthetics markets in the coming years. Growth will also be fueled by increased revenues from the aesthetic laser and light therapy segment, particularly in Spain and Germany, which have the largest aesthetic laser markets in Europe.

Read more on this interesting market in iData Research’s newest press release: